Skip to content

Effect of electroacupuncture for discogenic sciatica protocol of a randomised controlled trial

Effect of electroacupuncture for discogenic sciatica protocol of a randomised controlled trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15006370
Enrollment
Unknown
Registered
2015-05-07
Start date
2015-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sciatica

Interventions

Control group:Medium frequency electrotherapy

Sponsors

South Area of Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) met the diagnostic criteria of sciatica, and caused by lumbar disc herniation side pain; (2) the clinical features that at least one of the following characteristics: the lower extremity weakness, paresthesia, reflex activity decreased, leg pain radiating to the dermatomal distribution; (3) at the age of 18-70 years (including 18 years old and 70 years old); (4) check and treatment, and fill in the questionnaire and scale, informed consent, volunteered to participate in this study.

Exclusion criteria

Exclusion criteria: (1) in severe cases of cauda equina syndrome or foot drop, the absolute need operation treatment of patients, or within 6 months for lumbar intervertebral disc operation; (2) lumbar disc herniation after 3 months of conservative treatment is invalid, has continued to increase, with nerve root adhesion, or the healthy leg straight leg raising test was positive, or muscle atrophy; (3) due to other non lumbar disc herniation causes leg pain, numbness or weakness; (4) intervertebral disc herniation causing no sciatic nerve involvement symptoms and signs, or only the waist pain. (5) showed bilateral lower limb pain, numbness, weakness; (6) unconsciousness, cardiovascular, liver, kidney, gastrointestinal, hematopoietic system disease, or patients with tumor, infection, fracture, and psychiatric patients; (7) women who are pregnant or lactating women; (8) are participating in other clinical researchers; (9) pacemaker, metal allergy or severe fear of needle.

Design outcomes

Primary

MeasureTime frame
Change from baseline in average leg pain NRS in week 4.;

Countries

China

Contacts

Public ContactXue Zhang
zhangxueresume@aliyun.com+86 13260476371

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 27, 2026